menu close

Optimising pharmacovigilance for lifescience companies

We provide innovative software and specialist services that optimise business-critical pharmacovigilance processes for global pharmaceutical and life sciences companies – streamlining your regulatory and operational responsibilities to reduce costs, boost efficiency and increase compliance.

From automated Safety Document Distribution and data management to GxP-compliant hosting, PharmaLex is focused on delivering service and solution excellence, built on over two decades of unparalleled knowledge of the sector and a rich understanding of your complex business needs.

Safety Letter Notification

psiXchange automates the SUSAR distribution processes to sites, ECs, IRBs and others. This brings increased compliance to this complex distribution process for your critical safety documents.

Find Out More chevron_right

Safety Database

Our rapidLIVE solution delivers an accelerated, pre-packaged implementation for Oracle Argus Safety – currently hosted for many of the top global pharmaceutical companies and CROs

Find Out More chevron_right

20 years’ heritage in serving life sciences organisations worldwide.

PharmaLex enables organisations to effectively implement, automate and optimise key regulatory responsibilities across the entire pharmacovigilance function – including SUSAR document distribution via our industry-leading psiXchange platform.

Our full-service portfolio spans innovative software applications, specialist sector consultancy, GxP compliant hosting and gold-standard implementation services – including Argus rapidLIVE.

For over 20 years, we’ve been helping pharmaceutical, biotech and Clinical Research Organisations worldwide companies to efficiently meet their regulatory and operational responsibilities.

Find Out More chevron_right

News and events

PharmaLex newsletter: Autumn 2023

12th October 2023

Find out more chevron_right

PharmaLex newsletter: Spring 2023

25th May 2023

Find out more chevron_right

The Quest For Quality: Ensuring Good Clinical Practice in Clinical Trials

31st January 2023

Find out more chevron_right

We have worked with